Rupali, J. B. et al., Polymer Chemistry, 2023, 392-411,
http://dx.doi.org/10.1039/D2PY01217K
Alzheimer’s disease (AD) is a progressive neurodegenerative disease with no current cure and limited treatment solutions, wherefore discovering of novel therapies remains a global challenge in biopharmaceutical industries. This review article aims to summarize articles documenting synthetic polymer-based inhibitors of Aβ aggregations and highlight their potential as promising AD therapeutic agents. Published with a permission of the Royal Society of Chemistry 2023.